OncoDigicare

N/A

Published by: VCDoctor
Downloads
Revenue

Description

OncoDigiCare- is Telemedicine Platform allows healthcare providers to provide a Second Opinion related to Cancer diagnosis or treatment and to enhance patients and oncologist communication easy and effortless.

Screenshots

OncoDigicare FAQ

  • Is OncoDigicare free?

    Yes, OncoDigicare is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is OncoDigicare legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does OncoDigicare cost?

    OncoDigicare is free.

  • What is OncoDigicare revenue?

    To get estimated revenue of OncoDigicare app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in India yet.
Ratings History

OncoDigicare Reviews

No Reviews in India
App doesn't have any reviews in India yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

OncoDigicare Competitors

Name
VCDoctor
Health Zone
运动保持健康
HCP Space
Zevo Health
Mitone Active
CerraPoints
My Telehealth Africa
DocShowApp
eMedicalSentry
IMedicus

OncoDigicare Installs

Last 30 days

OncoDigicare Revenue

Last 30 days

OncoDigicare Revenue and Downloads

Gain valuable insights into OncoDigicare performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
VCDoctor
Languages
English
Recent release
1.1 (1 year ago )
Released on
Feb 21, 2023 (1 year ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.